297 related articles for article (PubMed ID: 18495100)
1. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells.
Oh W; Kim DS; Yang YS; Lee JK
Cell Immunol; 2008 Feb; 251(2):116-23. PubMed ID: 18495100
[TBL] [Abstract][Full Text] [Related]
2. Immune properties of human umbilical cord Wharton's jelly-derived cells.
Weiss ML; Anderson C; Medicetty S; Seshareddy KB; Weiss RJ; VanderWerff I; Troyer D; McIntosh KR
Stem Cells; 2008 Nov; 26(11):2865-74. PubMed ID: 18703664
[TBL] [Abstract][Full Text] [Related]
3. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression.
Klyushnenkova E; Mosca JD; Zernetkina V; Majumdar MK; Beggs KJ; Simonetti DW; Deans RJ; McIntosh KR
J Biomed Sci; 2005; 12(1):47-57. PubMed ID: 15864738
[TBL] [Abstract][Full Text] [Related]
4. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
[TBL] [Abstract][Full Text] [Related]
5. The immunobiological development of human bone marrow mesenchymal stem cells in the course of neuronal differentiation.
Liu CT; Yang YJ; Yin F; Wang X; Yu XH; Wang QH; Wang XL; Xie M
Cell Immunol; 2006 Nov; 244(1):19-32. PubMed ID: 17448455
[TBL] [Abstract][Full Text] [Related]
6. Characterization of mesenchymal stromal cells derived from full-term umbilical cord blood.
Manca MF; Zwart I; Beo J; Palasingham R; Jen LS; Navarrete R; Girdlestone J; Navarrete CV
Cytotherapy; 2008; 10(1):54-68. PubMed ID: 18202975
[TBL] [Abstract][Full Text] [Related]
7. Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism.
Chen K; Wang D; Du WT; Han ZB; Ren H; Chi Y; Yang SG; Zhu D; Bayard F; Han ZC
Clin Immunol; 2010 Jun; 135(3):448-58. PubMed ID: 20207200
[TBL] [Abstract][Full Text] [Related]
8. Although pig allogeneic mesenchymal stem cells are not immunogenic in vitro, intracardiac injection elicits an immune response in vivo.
Poncelet AJ; Vercruysse J; Saliez A; Gianello P
Transplantation; 2007 Mar; 83(6):783-90. PubMed ID: 17414713
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
Nasef A; Mathieu N; Chapel A; Frick J; François S; Mazurier C; Boutarfa A; Bouchet S; Gorin NC; Thierry D; Fouillard L
Transplantation; 2007 Jul; 84(2):231-7. PubMed ID: 17667815
[TBL] [Abstract][Full Text] [Related]
10. Immunologic properties of human fetal mesenchymal stem cells.
Götherström C; Ringdén O; Tammik C; Zetterberg E; Westgren M; Le Blanc K
Am J Obstet Gynecol; 2004 Jan; 190(1):239-45. PubMed ID: 14749666
[TBL] [Abstract][Full Text] [Related]
11. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities.
Magatti M; De Munari S; Vertua E; Gibelli L; Wengler GS; Parolini O
Stem Cells; 2008 Jan; 26(1):182-92. PubMed ID: 17901399
[TBL] [Abstract][Full Text] [Related]
12. A functional role for soluble HLA-G antigens in immune modulation mediated by mesenchymal stromal cells.
Rizzo R; Campioni D; Stignani M; Melchiorri L; Bagnara GP; Bonsi L; Alviano F; Lanzoni G; Moretti S; Cuneo A; Lanza F; Baricordi OR
Cytotherapy; 2008; 10(4):364-75. PubMed ID: 18574769
[TBL] [Abstract][Full Text] [Related]
13. 5-Azacytidine-treated human mesenchymal stem/progenitor cells derived from umbilical cord, cord blood and bone marrow do not generate cardiomyocytes in vitro at high frequencies.
Martin-Rendon E; Sweeney D; Lu F; Girdlestone J; Navarrete C; Watt SM
Vox Sang; 2008 Aug; 95(2):137-48. PubMed ID: 18557828
[TBL] [Abstract][Full Text] [Related]
14. Comparison of immunomodulatory properties of mesenchymal stem cells derived from adult human tissues.
Yoo KH; Jang IK; Lee MW; Kim HE; Yang MS; Eom Y; Lee JE; Kim YJ; Yang SK; Jung HL; Sung KW; Kim CW; Koo HH
Cell Immunol; 2009; 259(2):150-6. PubMed ID: 19608159
[TBL] [Abstract][Full Text] [Related]
15. Derivation and immunological characterization of mesenchymal stromal cells from human embryonic stem cells.
Trivedi P; Hematti P
Exp Hematol; 2008 Mar; 36(3):350-9. PubMed ID: 18179856
[TBL] [Abstract][Full Text] [Related]
16. A soluble product of human corneal fibroblasts inhibits lymphocyte activation. Enhancement by interferon-gamma.
Donnelly JJ; Xi MS; Rockey JH
Exp Eye Res; 1993 Feb; 56(2):157-65. PubMed ID: 8462649
[TBL] [Abstract][Full Text] [Related]
17. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
Krampera M; Cosmi L; Angeli R; Pasini A; Liotta F; Andreini A; Santarlasci V; Mazzinghi B; Pizzolo G; Vinante F; Romagnani P; Maggi E; Romagnani S; Annunziato F
Stem Cells; 2006 Feb; 24(2):386-98. PubMed ID: 16123384
[TBL] [Abstract][Full Text] [Related]
18. Umbilical cord blood-naive T cells but not adult blood-naive T cells require HLA class II on antigen-presenting cells for allo-immune activation.
Kloosterboer FM; van Luxemburg-Heijs SA; Willemze R; Falkenburg JH
Hum Immunol; 2004 Apr; 65(4):328-39. PubMed ID: 15120187
[TBL] [Abstract][Full Text] [Related]
19. Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro.
Gao L; Chen X; Zhang X; Liu Y; Kong P; Peng X; Liu L; Liu H; Zeng D
Blood Cells Mol Dis; 2006; 36(2):322-8. PubMed ID: 16500123
[TBL] [Abstract][Full Text] [Related]
20. Optimization of primary culture condition for mesenchymal stem cells derived from umbilical cord blood with factorial design.
Fan X; Liu T; Liu Y; Ma X; Cui Z
Biotechnol Prog; 2009; 25(2):499-507. PubMed ID: 19319963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
